Back

New frontiers in the management of amyloid heart disease.

22 May 2022 (16:14 - 16:26)
Organised by:
Congress Presentation Part of: Optimal therapeutic approach in cardiomyopathies Myocardial Disease HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

4 More presentations in this session

Presentation thumbnail
Etiology-based and device treatment in dilated cardiomyopathy.
Professor P. Seferovic (Belgrade, RS)
Slides Video
Presentation thumbnail
Novel treatments in hypertrophic cardiomyopathy
Professor M. Tome Esteban (London, GB)
Slides Video
Presentation thumbnail
Genetic-phenotype therapeutic approach in arrhythmogenic right ventricular cardiomyopathy.
Professor E. Behr (London, GB)
Slides Video
Presentation thumbnail
Optimal therapeutic approach in cardiomyopathies - discussion.
Video

Access the full session

Session thumbnail
Optimal therapeutic approach in cardiomyopathies
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 16:14 CET
You may be interested in
thumbnail
Congress Presentation
Therapy of amyloidosis
22 May 2023
thumbnail
Congress Presentation
Welcome and introduction: the origin and evolution of the disease.
22 May 2022
thumbnail
Congress Session
From clone control to fibril clearance: an amyloidosis update for daily practice
19 June 2026
thumbnail
Congress Presentation
What is on the horizon?
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources